Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1953919rdf:typepubmed:Citationlld:pubmed
pubmed-article:1953919lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1953919lifeskim:mentionsumls-concept:C0002092lld:lifeskim
pubmed-article:1953919lifeskim:mentionsumls-concept:C0946568lld:lifeskim
pubmed-article:1953919lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:1953919lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:1953919lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:1953919lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1953919pubmed:dateCreated1991-12-30lld:pubmed
pubmed-article:1953919pubmed:abstractTextSpecific immune responsiveness to the Amb a V allergen (from Ambrosia artemisiifolia, short ragweed pollen) is significantly associated with the Class II specificities, human leucocyte antigen (HLA)-DR2 and Dw2 determined by serological and MLR typing ("DR2.2"). Similarly, responsiveness to homologous Amb t V and Amb p V allergens is associated with DR2.2. We examined the deoxyribonucleic acid (DNA) sequences of HLA-DRB1, DRB5, DQB1 and DQA1 genes associated with Amb a V responsiveness using a combination of polymerase chain reaction (PCR), dot-blot and DNA sequencing methodologies. Our focus was on the highly polymorphic regions within the second-exon gene segments that are believed to encode antigen (Ag)-binding portions of the respective Class II molecules. Analysis of three patients having unusual sequence combinations of HLA-D gene sequences implicate an HLA-DR molecule (either DR alpha beta I 2.2 or DR alpha beta V 2.2), rather than a DQ Class II molecule, as the major Amb a V immune response (Ir) gene product. Our studies suggest that this DR2.2 molecule is usually a necessary, and almost always a sufficient, requirement for high immunoglobulin E and G (IgE) and (IgG) antibody responsiveness in ragweed-allergic individuals. From an atopic DR2.2+ subject, we isolated three Amb a V-specific T-cell clones. Analysis revealed these clones to be DR-restricted, supporting the conclusion that the Amb a V-Ir gene is a DR and not a DQ molecule. The DR beta I polypeptide of DR2.2 and 2.12 was implicated in Ag presentation, since monoclonal antibody (MoAb) Hu30 (antibody specific for DR beta I) blocked T-cell proliferation.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1953919pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1953919pubmed:languageenglld:pubmed
pubmed-article:1953919pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1953919pubmed:citationSubsetIMlld:pubmed
pubmed-article:1953919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1953919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1953919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1953919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1953919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1953919pubmed:statusMEDLINElld:pubmed
pubmed-article:1953919pubmed:monthAprlld:pubmed
pubmed-article:1953919pubmed:issn0904-1850lld:pubmed
pubmed-article:1953919pubmed:authorpubmed-author:MarshD GDGlld:pubmed
pubmed-article:1953919pubmed:authorpubmed-author:HuangS KSKlld:pubmed
pubmed-article:1953919pubmed:authorpubmed-author:ZwolloPPlld:pubmed
pubmed-article:1953919pubmed:issnTypePrintlld:pubmed
pubmed-article:1953919pubmed:volume13lld:pubmed
pubmed-article:1953919pubmed:ownerNLMlld:pubmed
pubmed-article:1953919pubmed:authorsCompleteYlld:pubmed
pubmed-article:1953919pubmed:pagination60s-67slld:pubmed
pubmed-article:1953919pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:meshHeadingpubmed-meshheading:1953919-...lld:pubmed
pubmed-article:1953919pubmed:year1991lld:pubmed
pubmed-article:1953919pubmed:articleTitleMolecular and cellular studies of human immune responsiveness to the short ragweed allergen, Amb a V.lld:pubmed
pubmed-article:1953919pubmed:affiliationDivision of Clinical Immunology, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD 21224.lld:pubmed
pubmed-article:1953919pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1953919pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1953919pubmed:publicationTypeReviewlld:pubmed